News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Molecular Profiles and Onyx Scientific Limited Form Strategic Alliance Spanning Drug Discovery to Manufacture



8/13/2012 9:46:35 AM

(Nottingham, 13 August 2012) Molecular Profiles, a leading specialist contract research and manufacturing organisation, announced that it has entered into a strategic alliance with Onyx Scientific, a contract manufacturing organisation offering chemistry services to large and emerging pharmaceutical and biotech companies worldwide. The partnership enables the two companies to deliver end-to-end services from initial drug discovery through to early and late phase manufacturing. The newly formed alliance means that customers of both Molecular Profiles and Onyx Scientific will have access to a wider range of services with the added benefit of a consistent team and delivery. The complementary alliance benefits from Onyx Scientific’s specialism in active pharmaceutical ingredient (API) production and initial solid state screening, combined with Molecular Profiles’ expertise in formulation and analytical development and early phase clinical trial manufacturing. Onyx Scientific also has sites in India providing customers with late stage clinical trial and commercial manufacturing services, completing the full service offering and accelerating drug candidates from discovery through to manufacture.

As the services offered by the two companies are well aligned, including a shared expertise in the area of solid state characterization, customers can expect a seamless and fully integrated service throughout the full drug discovery, development and manufacturing process. Customers also have the flexibility to select individual services from the full range to match their specific requirements.

Denise Bowser, Commercial Director at Onyx Scientific comments: “We are excited that the combination of the two companies will be able to offer customers the full range of chemistry and formulations services. Technical teams across these two best-in-class organisations will be routinely working together and our customers can rest assured that they will receive a seamless service throughout their drug discovery and development programmes.”

Claire Madden-Smith, Commercial Director at Molecular Profiles comments: “We are delighted to have partnered with Onyx Scientific and look forward to realising the benefits of this strategic alliance. Our customers are now able to access services ranging from API production through to formulation development and late stage manufacturing, providing flexibility and the opportunity to experience a consistent delivery across these stages.”

More information about Molecular Profiles’ award-winning services is available at www.molprofiles.co.uk, by e-mail at info@molprofiles.co.uk or call Claire Madden-Smith on +44 115 8718888.

About Molecular Profiles

Molecular Profiles was founded in 1997 by a group of pharmaceutical scientists specialising in advanced characterisation of pharmaceutical and biological materials. Since then, the company has achieved a unique global position in pharmaceutical R&D and has developed a wide portfolio of pharmaceutical development services including formulation & analytical development and clinical trial manufacturing up to and including Phase II. The company is ideally placed to offer its clients a range of targeted solutions to help them to overcome the most challenging issues in drug development. Molecular Profiles’ contribution to the industry was acknowledged in 2007 and 2011 by the receipt of the Queens Award for Enterprise in the innovation category, the most prestigious business honour achievable in the UK.

About Onyx Scientific

Onyx Scientific is a contract manufacturing organisation (CMO) that provides chemistry services to large and emerging pharmaceutical and biotech companies across the globe and helps accelerate candidates from discovery to production. The company was set-up in the UK in 2000 and has grown by consistently delivering top-notch chemical and API manufacturing services to support life science clients. In 2011, the company was acquired and proudly became part of the Ipca Laboratories family. Onyx Scientific’s UK site is staffed with around 40 staff and the company has over 4000 personnel across different locations in India. As a specialist contract manufacturing organisation, Onyx Scientific is dedicated to providing high quality chemistry and API production services to its clients.

For further press information please contact: Lindsay Baldry, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA, United Kingdom. Tel: + 44 1477 539 539 Fax: +44 1477 539 540 E-mail: molecular@scottpr.com.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES